How effective were neuraminidase inhibitors during the 2009 pandemic?Archived
This systematic review and meta-analysis of observational data from an established group of specialists assessed treatment outcomes for all three neuraminidase inhibitors (NAIs); oseltamivir, zanamivir and peramivir given to hospitalised patients with influenza A(H1N1)pdm09 during the 2009 pandemic.
New (Post Pandemic 2009) UK Influenza Pandemic Preparedness StrategyArchived
Following an earlier consultation document issued in March 2011 the UK’s Secretary of State for Health, along with the UK’s developed administrations (N. Ireland, Scotland and Wales) published a new influenza pandemic strategy on 10 November.
Two evaluations of the response to the 2009 Pandemic in Spain: Surveillance and Vaccines and antiviralsArchived
Two official evaluations have been made by the national Ministry of Health of Spain of their country’s response to the 2009 influenza pandemic. The reviews focused on two particular topics - Surveillance and Vaccines and Antivirals.
Virological Risk Assessment of Pandemic Potential - EFSA Call for proposalsArchived
The European Food Standard Agency has recently published a call for proposals for a methodological framework for potentially pandemic influenza strains.
Poor pregnancy outcomes associated with maternal infection with the A(H1N1) 2009 virus during the pandemic – findings from a European cohort studyArchived
This large national cohort study followed-up pregnant women admitted to hospital and found to have laboratory-confirmed influenza A(H1N1) 2009 infection during the autumn-winter wave of the 2009 pandemic. The main objective was determining any adverse pregnancy outcomes attributable to the infection.
The 2009 A(H1N1) pandemic in Europe, a review of the experience
This extended report aims to provide a broad overview of the epidemiology and virology of the 2009 pandemic in the European Union and European Economic Area countries. The main trends and information are derived from the analysis and interpretation of the epidemiological and virological data and other analyses provided to the European Centre for Disease Prevention and Control’s European Surveillance system through the European Influenza Surveillance Network.
Interim technical guidance on public health use of influenza antivirals during influenza pandemics
Antiviral drugs are an important addition to the public health arsenal against influenza. This interim guidance discusses the options for their effective use, especially during a pandemic.
Interim technical guidance on use of specific pandemic influenza vaccines during the H1N1 2009 pandemic
This interim guidance outlines the possible strategies that countries may wish to adopt in the deployment of a pandemic-specific vaccine, considering the two objectives of vaccination: protecting those at greatest risk of severe disease and maintaining essential services.
Guide to public health measures to reduce the impact of influenza pandemics in Europe – ‘The ECDC Menu’
This document presents a menu of possible public measures to be taken during influenza pandemics, giving public health and scientific information on what is known or can be said about their likely effectiveness, costs (direct and indirect), acceptability, public expectations and other more practical considerations. The ‘ECDC Menu’ aims to help EU Member States and institutions, individually or collectively, decide which measures they will apply.
Technical guidance on mitigation and delaying (or ‘containment’)strategies as the new influenza A(H1N1) virus comes into Europe
As epidemics of the new influenza A(H1N1) virus are extending globally, some European countries are considering how robustly to undertake case-finding among the first cases and whether to pursue and treat contacts.